MEDICUS PHARMA LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
MEDICUS PHARMA LTD. (MDCX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 3.05 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- MEDICUS PHARMA LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 2.08M shares.
- MEDICUS PHARMA LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 975.00K shares.
- MEDICUS PHARMA LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 685.00K shares.
- MEDICUS PHARMA LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 725.00K shares.
- MEDICUS PHARMA LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.51M shares, a 211.34% increase from fiscal 2024.
- MEDICUS PHARMA LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 485.00K shares, a 40.31% decline from fiscal 2023.
- MEDICUS PHARMA LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 812.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.08M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 3.05M shares 10-Q · filed 2026-08-12 | 3.73M shares derived: sum of 3 quarters · filed 2026-08-12 | 4.46M shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 975.00K shares 10-Q · filed 2026-05-14 | 1.66M shares derived: sum of 2 quarters · filed 2026-05-14 | 2.38M shares derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | 685.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 1.41M shares derived: sum of 2 quarters · filed 2026-03-25 | 1.51M shares 10-K · filed 2026-03-25 | |
| 2025-09-30 | 725.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 825.00K shares 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | 100.00K shares 10-Q · filed 2026-08-12 | |||
| 2024-12-31 | 485.00K shares 10-K · filed 2026-03-25 | |||
| 2023-12-31 | 812.50K shares 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |